Humanin: Dosage, Protocol, and Research Guide
Mitochondrial-derived peptide with neuroprotective and metabolic benefits
Mechanism
Protects against apoptosis, improves insulin sensitivity, reduces oxidative stress, activates STAT3 signaling
Protocol at a glance
| Starting dose | 1mg |
|---|---|
| Maintenance dose | 2-5mg |
| Maximum dose | 5mg |
| Frequency | Daily or 3x weekly |
| Typical duration | 8-12 weeks |
| Route | Subcutaneous |
| Injection site | Abdomen |
| Timing | Morning |
Side effects
- Minimal - mild injection site reactions
Contraindications
- Limited data - caution in pregnancy
Protocol notes
- Protects neurons from damage
- Improves metabolic health
- May enhance longevity
- Reduces oxidative stress
- Limited human studies available
Frequently asked questions
Is Humanin legal?
Humanin is not FDA-approved for human use and is available exclusively for research purposes. Its legal status varies by jurisdiction, and individuals interested in research protocols should consult local regulations and a licensed physician. Humanin should only be obtained and used in legitimate research contexts under appropriate medical supervision.
What is the correct Humanin dosing protocol?
Humanin follows a specific dosing structure in research protocols. Initial dosing begins at 1mg, with maintenance doses typically ranging from 2-5mg per injection, and a maximum dose of 5mg established as the ceiling. Humanin is administered via subcutaneous injection to the abdominal region, with morning injection timing recommended. Standard protocols employ either daily injection or three-times-weekly dosing over an 8-12 week cycle duration.
What are the side effects of Humanin?
Humanin exhibits a favorable safety profile based on available research data. The primary adverse effect reported is mild injection site reactions at the subcutaneous injection location. Caution is advised in pregnancy due to limited safety data in this population. Beyond these parameters, research on side effects remains limited. Any use should be monitored by a qualified healthcare provider.
How does Humanin work?
Humanin is a mitochondrial-derived peptide that protects cells against apoptosis and activates critical signaling pathways including ERK1/2, AKT, and STAT3. These mechanisms combine to reduce oxidative stress, improve insulin sensitivity, and provide neuroprotection by protecting neurons from damage. This multi-pathway activation addresses both metabolic health and neurological resilience.
How long should you use Humanin?
Standard research protocols for Humanin employ an 8-12 week cycle duration. This timeframe allows adequate accumulation of effects and permits measurement of changes in relevant biomarkers and biological processes. The duration aligns with typical peptide research protocols and provides sufficient time to assess neuroprotective effects, oxidative stress reduction, and metabolic changes.
What biomarkers does Humanin improve?
Humanin's mechanisms suggest measurable effects on biological markers relevant to aging and metabolic health. The peptide improves insulin sensitivity, a key indicator of metabolic function. Additionally, Humanin's activation of STAT3 signaling and reduction of oxidative stress suggest effects on biomarkers related to cellular stress and oxidative damage. Research on specific biomarker changes in human subjects remains limited.
Can you stack Humanin with other peptides?
Research on combining Humanin with other peptides or compounds remains limited. Available studies focus primarily on Humanin's independent mechanisms through ERK1/2, AKT, and STAT3 signaling. Data on synergistic effects or interactions with other compounds is not well-established. Any consideration of combining Humanin with other peptides should be discussed with a qualified healthcare provider.
More Longevity & Anti-Aging peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.